Mrs. Ingrid Liddell Goganious, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2204 Herring Creek Dr, Accokeek, MD 20607 Phone: 301-203-7186 |
News Archive
BioSphere Medical, Inc. – the leader in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – today announced the submission to the U.S. Food and Drug Administration (FDA) of an Investigational Device Exemption (IDE) application for a clinical trial for the use of BioSphere's QuadraSphere® Microsphere product (QuadraSphere) to deliver the chemotherapeutic agent doxorubicin for the treatment of primary liver cancer.
KemPharm, Inc., a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary new molecular entity (NME) prodrugs, announced today that it received a No Objection Letter (NOL) from Health Canada to begin clinical trials in Canada for its lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen)
Stay Staffed Technologies announced today their newly updated website includes new client resources such as case studies, product reviews, and healthcare IT resource links and more. The suite of workforce management software heightens the efficiency and staff productivity of hospitals while reducing operational expenses associated with costly third-party vendors, health care staffing overtime, and burdensome manual systems.
Reducing high concentrations of a fatty molecule that is commonly found in people with diabetes and nonalcoholic fatty liver disease rapidly improves insulin sensitivity, UT Southwestern Medical Center diabetes researchers have found.
› Verified 2 days ago